Insider transactions at major firms show executives divesting holdings, while Pfizer directors exhibit mixed buying and selling activity.
Executives at Microsoft and Meta sold portions of their holdings this week, with transactions occurring between August 3 and August 7. The sales ranged from under 1% to over 13% of individual holdings, reflecting significant divestment by some insiders.
Other firms saw varied activity, including Pfizer, where some executives sold shares while directors made purchases. Taiwan Semiconductor and Tilray Brands also recorded notable insider trades, highlighting divergent strategies among corporate leaders.
The transactions suggest differing views on company valuations or personal liquidity needs, though no immediate market reaction was reported.